Cefepime clinical trials
Also written Maxipime.
Counted the way a researcher would: Cefepime with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Cefepime is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Cefepime studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 18 Jan 1996 · MAXIPIME · NDA 050679 (FDA, Drugs@FDA)
- European Union
- 21 Mar 2024 · Exblifep · EMEA/H/C/005431 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
22 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 3 |
| 2021 | 3 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 15
Allecra (2) · Wockhardt (2) · Janssen Research & Development, LLC (2) · Memorial Sloan Kettering Cancer Center (1) · Beni-Suef University (1) · Murdoch Childrens Research Institute (1) · Centre Hospitalier Universitaire de Besancon (1) · Indonesia University (1)
Often tested with
Tested in the same studies.
Piperacillin, Tazobactam Drug Combination (4) · Vancomycin (3) · Meropenem (3) · Piperacillin (2) · Tazobactam (2) · Enmetazobactam (2) · Ceftriaxone (2) · Levofloxacin (2)
Related medicines
As reviewed, each with the page that says it.
- One of Cephalosporins source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Cefepime.
- Feb 2027Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell TransplantPhase 2 · Memorial Sloan Kettering Cancer Center
Studies
Open first, then newest update. How each study uses Cefepime is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTIRecruitingPhase 2Orchid Pharma Europe GmbHNCT05826990Written as cefepime and enmetazobactam combination
- A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized PatientsRecruitingPhase 4University of PennsylvaniaNCT06954129Written as Cefepime
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedPhase 4Murdoch Childrens Research InstituteNCT04948463Written as Cefepime Injection
- Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell TransplantActive, not recruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT03078010Written as cefepime
- Early Antibiotics After Aspiration in ICU PatientsTerminatedPhase 4UConn HealthNCT05079620Written as Cefepime
- PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockCompletedPhase 3Centre Hospitalier Universitaire de BesanconNCT02820987Written as CEFEPIME
- Cefepime and Unictam on Preventing Post-Cesarean Surgical Site InfectionsActive, not recruitingPhase 3Beni-Suef UniversityNCT06048692Written as Cefepime 1000 MG
- Antibiotics Continuous Infusion at HomeStatus unknownPhase 1Ospedale San Carlo BorromeoNCT04816968Written as Cefepime
- Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic PatientsStatus unknownPhase 4Hospital Universitari de BellvitgeNCT04233996Written as Cefepime 2000 mg
- Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic FeverCompletedPhase 4Indonesia UniversityNCT04187755Written as Cefepime Injection
- Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean SectionStatus unknownPhase 2/3Assiut UniversityNCT04009772Written as Cefepime
- Investigation of AAI101 Safety, Tolerability & PK in Healthy VolunteersCompletedPhase 1AllecraNCT03685084Written as Cefepime i.v.
- Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTICompletedPhase 2AllecraNCT03680612Written as Cefepime 1G - 2G / AAI101 0.5G - 0.75G
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedPhase 1Wake Forest University Health SciencesNCT01484015Written as cefepime hydrochloride
- Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated PeritonitisCompletedPhase 4Chulalongkorn UniversityNCT02872038Written as Cefepime
- A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal ImpairmentCompletedPhase 1WockhardtNCT02709382Written as Cefepime and Tazobactam combination
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With CefepimeCompletedPhase 1WockhardtNCT02532140Written as Cefepime 2000 mg
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTerminatedPhase 3Janssen Research & Development, LLCNCT01110421Written as Cefepime
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract InfectionsTerminatedPhase 3Janssen Research & Development, LLCNCT01110408Written as Cefepime
- Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaStatus unknownPhase 3Jonsson Comprehensive Cancer CenterNCT00020865Written as cefepime hydrochloride
See all 22 studies that test Cefepime →
Given beside what is tested · 9 — Cefepime is usual care or a partner of the new treatment
- Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)TerminatedPhase 4West Virginia UniversityNCT05156437Written as Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline
- P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant EnterobacteralesCompletedPhase 3Meiji Seika Pharma Co., Ltd.NCT05905055Written as co-administration of cefepime and nacubactam
- Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated PyelonephritisCompletedPhase 3Meiji Seika Pharma Co., Ltd.NCT05887908Written as co-administration of cefepime and nacubactam
- Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy VolunteersCompletedPhase 1Nanjing Yoko Biomedical Co., Ltd.NCT05588531Written as Group 6:YK-1169/Cefepime hydrochloride for injection/Avibactam for injection
- Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy SubjectsCompletedPhase 1AllecraNCT03680352Written as cefepime/AAI101
- Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract InfectionsCompletedPhase 3AllecraNCT03687255Written as cefepime/AAI101 combination
- Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult SubjectsCompletedPhase 1Venatorx Pharmaceuticals, Inc.NCT03870490Written as VNRX-5133 + cefepime
- VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal ImpairmentCompletedPhase 1Venatorx Pharmaceuticals, Inc.NCT03690362Written as VNRX-5133 and VNRX-5022
- VNRX-5133 Drug-Drug Interaction in Healthy Adult VolunteersCompletedPhase 1Venatorx Pharmaceuticals, Inc.NCT03332732Written as VNRX-5022
As the comparator · 9 — what is tested is compared with Cefepime
- PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINCompletedPhase 2M.D. Anderson Cancer CenterNCT04983901Written as Cefepime
- Comparing Oral Versus Parenteral Antimicrobial TherapyTerminatedPhase 4West Virginia UniversityNCT05977868Written as Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
- Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-TazobactamCompletedPhase 2M.D. Anderson Cancer CenterNCT03485950Written as Cefepime
- Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)CompletedPhase 2PfizerNCT02497781Written as Cefepime
- Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic DiseasesCompletedPhase 3Center for Supporting Hematology-Oncology TrialsNCT00137787Written as cefepime
- An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract InfectionsTerminatedPhase 3TakedaNCT02302092Written as Cefepime
- Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With CancerTerminatedPhase 2Forest LaboratoriesNCT02732327Written as Cefepime
- Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment FailureCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01852630Written as cefepime + Albumin
- A Study of Ceftobiprole in Patients With Fever and Neutropenia.TerminatedPhase 3Basilea PharmaceuticaNCT00529282Written as Cefepime with or without vancomycin
Codes
What other systems call Cefepime · ClinicalTrials.gg INT006791
- MeSH (NLM) D000077723CefepimeConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 807PW4VQE3CEFEPIMEConfirmed FDA, NLM, Wikidata
- RxNorm 20481Confirmed FDA, Wikidata
- Wikidata Q2552927cefepimeConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65294CefepimeOne source FDA
- DrugBank DB01413One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077723 | Cefepime | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 807PW4VQE3 | CEFEPIME | Confirmed FDA, NLM, Wikidata |
| RxNorm | 20481 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2552927 | cefepime | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65294 | Cefepime | One source FDA |
| DrugBank | DB01413 | — | One source Wikidata |
Also registered as cefepime hydrochloride (UNII I8X1O0607P · RxNorm 236058).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.